Delivery Order SPE2DB22D9151-SPE2DB25FM8HK
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,612.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of April 1, 2022, is for the procurement of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes and has an ultimate completion date of December 19, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,737 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 75 mg/0.5 ml syringe 0.5 ml, with an ultimate completion date of October 30, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $38,685.00, is for the supply of the pharmaceutical product Xolair 150 mg/ml syringe. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,557.52, is for the supply of Xolair 150 mg/ml syringes. This award is under a larger DLA medical supply chain indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,605.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through August 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB25FM8HKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/1.2 ml powder vials. The contract is firm fixed-price with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards from the DLA covering prescription medications, biologics, and medical consumables. The company's core business involves distributing branded and generic drugs to military and federal healthcare systems nationwide. This particular delivery order for Xolair, a biologic medication used in respiratory and dermatological treatments, reflects the company's continued role as a primary pharmaceutical supplier to the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 8/18/25 |